ArticleFrontiers in aging neuroscience2026

Next-generation TREM2-targeted therapies for Alzheimer's disease: insights and directions from the INVOKE-2 trial.

Mingsong ShiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.